Skip to main content

Day: August 18, 2020

Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce Agreement to Make Firdapse® (amifampridine phosphate) Available to LEMS Patients in Canada

CORAL GABLES, Fla., Aug. 18, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, and KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario and focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian market, today announced that the companies have entered into an exclusive license agreement under which KYE will commercialize Firdapse® in Canada. Firdapse® is indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. Under the terms of the agreement, Catalyst will supply Firdapse® to KYE and KYE...

Continue reading

XBiotech étudie une piste thérapeutique contre le COVID-19

AUSTIN, Texas, 18 août 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui avoir identifié des anticorps True Human pouvant potentiellement être utilisés comme traitement contre le SARS-CoV2, le virus responsable du COVID-19. La société a découvert ces anticorps dans le cadre d’une collaboration avec BioBridge Global, société mère du South Texas Blood & Tissue Center et de QualTex Laboratories, l’un des plus grands laboratoires d’essais indépendant aux États-Unis.Pour cette collaboration, BioBridge Global a utilisé la technologie brevetée de dépistage du COVID-19 de XBiotech pour identifier des donneurs de sang ayant été infectés par le nouveau coronavirus, dans le cadre d’un programme qui vise à fournir un plasma en phase de convalescence pour traiter les patients ayant...

Continue reading

XBiotech entdeckt Kandidaten für COVID-19-Therapie

AUSTIN, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) hat heute bekanntgegeben, dass es True Human-Antikörper identifiziert hat, die möglicherweise als Therapie gegen SARS-CoV2, das Virus, das COVID-19 verursacht, eingesetzt werden könnten. Das Unternehmen hat diese Antikörper in Zusammenarbeit mit BioBridge Global (der Mutterorganisation des South Texas Blood & Tissue Center und QualTex Laboratories, einem der größten unabhängigen Testlabors in den USA) entdeckt.Für die Zusammenarbeit verwendete BioBridge Global die unternehmenseigene COVID-19-Screening-Technologie von XBiotech, um Blutspender zu identifizieren, die mit dem neuartigen Coronavirus infiziert waren. Dies war Teil eines Programms zur Bereitstellung von Rekonvaleszenten-Plasma zur Behandlung von Patienten mit schweren COVID-19-Infektionen....

Continue reading

Location Analytics Market to Grow at 16.5% CAGR till 2026; Increasing Demand for Efficient Geospatial Data Analysis Tools to Foster Growth Opportunities: Fortune Business Insights™

Pune, Aug. 18, 2020 (GLOBE NEWSWIRE) — The global location analytics market size is projected to reach USD 26.75 billion by the end of 2026. The increasing investment in product R&D will have a direct impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Location Analytics Market Size, Share & Industry Analysis, By Component (Solution, Services), By Location Type (Indoor, Outdoor), By Deployment Type (Cloud, On-Premises), By End-User (Retail, Government, Energy and Utilities, Healthcare, Travel and Transportation, Telecommunications, and Others) and Regional Forecast, 2019-2026,” the market was worth USD 8.16 billion in 2019 and will exhibit a CAGR of 16.5% during the forecast period, 2019-2026.The confluence of Artificial Intelligence (AI) with location...

Continue reading

Kvika banki hf.: Leiðrétting – Árshlutareikningur – 6 mán

Í íslenskri útgáfu tilkynningar sem birtist frá bankanum kl. 11:11 í dag var tímasetning kynningarfundar vegna afkomu fyrstu 6 mánuða ársins 2020 misrituð. Hið rétta er að fundurinn verður haldinn klukkan 11:45 næstkomandi föstudag, 21. ágúst.Kvika banki hf.: Árshlutareikningur – 6 mánKvika banki hf. mun birta afkomu vegna fyrstu sex mánaða ársins 2020 fimmtududaginn 20. ágúst, eftir lokun markaða. Kynningarfundur fyrirfjárfesta verður haldinn í höfuðstöðvum bankans á 9. hæð, Katrínartúni 2, Reykjavík, föstudaginn 21. ágúst kl. 11:45. Boðið verður upp á léttar veitingar.Vakin er athygli á því að fyrirmælum yfirvalda um sóttvarnir verður fylgt í hvívetna á fundinum, m.a. hvað varðar hreinlæti, fjöldatakmörkun og fjarlægð milli fundarmanna. Fjárfestakynning sem farið verður yfir á fundinum verður aðgengileg fyrir fundinn.

Continue reading

Acreage Holdings Announces Filing of Proxy Statement Related to Amended Arrangement with Canopy Growth

NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or “the Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) is pleased to announce that it: (i) obtained an interim order (the “Interim Order”) of the Supreme Court of British Columbia (the “Court”) in connection with its proposed amended arrangement (the “Amended Arrangement”) involving Canopy Growth Corporation (“Canopy Growth”) to be implemented under a statutory plan of arrangement pursuant to section 288 of the Business Corporations Act (British Columbia); and (ii) filed its proxy statement and management information circular (collectively, the “Circular”) and related materials (the “Meeting Materials”) in respect of the special meeting of Acreage shareholders (the “Shareholders”) to be held on September 16, 2020 (the “Meeting”) to approve the Amended...

Continue reading

Biofertilizers Market Size to Reach USD 3.28 Billion by 2027: Increasing Need to Increase Soil Fertility to Boost Growth, says Fortune Business Insights™

Pune, Aug. 18, 2020 (GLOBE NEWSWIRE) — The global biofertilizers market size is likely to rise at a CAGR of 10.9% between 2020 and 2027 on account of the increasing demand for chemical-free fertilizers for agricultural production. In May 2016, Lage y Cia, a company in Uruguay was acquired by a Canadian company Lallemand Inc., for increasing the production of yeast, fungi, and bacteria as a biocontrol, biofertilizer, and a biostimulant agent. According to a recent report by Fortune Business Insights titled, “Biofertilizers Market Size, Share & COVID-19 Impact Analysis, By Type (Nitrogen Fixing, Phosphate Solubilizers, and Others), Microorganism (Rhizobium, Azotobacter, Azospirillum, Pseudomonas, Bacillus, VAM, and Others), Application (Seed Treatment, Soil Treatment, and Others), Crop Type, and Regional Forecast, 2020 – 2027,”...

Continue reading

DIOS Grants an Option on 33 Carats-Bohier Gold Project

MONTREAL, Quebec, Aug. 18, 2020 (GLOBE NEWSWIRE) — Dios Exploration Inc. is pleased to report signing an agreement with a private Australian company (“the buyer”) allowing the latter to acquire an interest in the 33 Carats-Bohier property (“33 Carats”) located along the Upper Eastmain River in the Otish Mountains region of Quebec, in James Bay Eeyou-Istchee. The buyer can earn a 70% interest in this property over a five-year period with payments of $ 220,000 and exploration work totaling $ 1,400,000. Once the 70% interest is obtained, the buyer can obtain an additional interest of 15% following the preparation by the buyer of a preliminary economic study of the property.M.-J. Girard, President of Dios, stated “We are pleased to welcome a new partner to develop the strong potential of the 33 Carats gold...

Continue reading

DIOS signe une entente sur son projet d’or 33 Carats-Bohier

MONTRÉAL, Québec, 18 août 2020 (GLOBE NEWSWIRE) — DIOS EXPLORATION INC. a signé une entente avec une société privée australienne (“l’acheteur”) permettant à cette dernière d’acquérir une participation dans la propriété 33Carats-Bohier située le long de la rivière Eastmain dans la région des monts Otish au Québec, en territoire Baie James Eeyou Istchee. L’acheteur peut obtenir une participation de 70% sur une période de cinq ans avec des paiements de 220 000$ et des travaux d’exploration totalisant 1 400 000$. Une fois la participation de 70% obtenue, l’acheteur pourra obtenir un intérêt supplémentaire de 15% suite à la préparation par l’acheteur d’une étude économique préliminaire de la propriété.  Le projet 33Carats-Bohier est localisé directement au nord-ouest de la propriété...

Continue reading

Better Choice Company Reports Second Quarter 2020 Financial Results

NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an animal health and wellness company, today reported its financial results for the second quarter ended June 30, 2020.“We are excited to share our second quarter 2020 results with the investor community. We have made significant progress at Better Choice in the first half of 2020, including integrating the recent Halo acquisition, expanding our e-commerce platform and accelerating our international business in Asia,” said Werner von Pein, CEO of Better Choice.“The e-commerce and direct-to-consumer channels account for approximately 60% of our sales. Recent events surrounding COVID-19 have accelerated the shift toward online purchases of pet products, and Better Choice is well positioned in these channels of trade...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.